Latest Insights on PHAR
Genes Get Wilder: 23andMe, You & Big Brother June 19, 2021 Great Stuff What’s The Deal With 23andMe? Great Ones, what do you know about 23andMe (Nasdaq: )? Some of you probably know 23andMe from its home testing kits. No, not home drug tests — genetic tests that tell you where your ancestors came from. 23andMe’s tests were a popular holiday/birthday gift a few years ago. According to […]
The Great Rebalancing, Boeing Vs. China, Dirty Deeds Done Draftkings June 15, 2021 Great Stuff The Great Rebalancing Great Ones, I’m no high-flying, high-profile Wall Street talking head. If I was, you probably wouldn’t be getting Great Stuff for free. Like Zaphod Beeblebrox … I’m just this guy, you know? But even I can see the writing on the wall when it comes to the U.S. economy and Wall Street’s […]
Biogen’s $56,000 Question, Tangled Up In Tesla & Fastly Goes The Internet June 8, 2021 Great Stuff Biogen: Before I Forget Great Ones, I don’t usually get personal in Great Stuff. But this news on Biogen’s (Nasdaq: ) Alzheimer’s drug has me on edge today. You see, my grandfather died of Alzheimer’s. It’s been more than a decade since he passed, but some wounds never fade. I still remember watching Indiana Jones, […]
Great Stuff Picks Takes Profits, Wi-fi 6 Versus 5G & The Epic Apple Debate May 27, 2021 Great Stuff Good Times Bad Times In the days of my youth, I was told what it means to trade like a man. Now I’ve reached that age, I’ve tried to do all those things the best I can. Good times, bad times … we’ve all had our share, Great Ones. Wait … isn’t it Thursday? Where’s […]
The No. 1 Health Care ETF for the Vaccine Race May 26, 2021 American Investor Today, News, U.S. Economy (4-minute read) Vaccines are being distributed across the country. And it’s showing us exactly how far we’ve come in health care technology. Here’s one way to profit…





